Aurora Cannabis’s (TSX:ACB)(NYSE:ACB) founder, director, and former CEO Terry Booth has made a massive sale of 12,161,900 shares on his Aurora Cannabis stock position on the open market over the past few days. Should investors read much into this corporate insider’s latest move? Mr. Booth made four separate large sell transactions of millions of Aurora shares at stock prices ranging…
Read More
The past two years have been a roller coaster ride for marijuana investors. In 2018, cannabis stocks were regularly doubling in price. In 2019, they were regularly halving in the price. Despite the whirlwind, the pot industry still has a strong decade of growth ahead of it. Cowen Inc, the leading voice on cannabis stocks, thinks that the U.S. will…
Read More
Analyzing all the new companies in the recently legalized cannabis industry is no easy matter. The reason is that there is no track record – everything is new. The industry & companies are new, management is new, all the employees, everything they do and how they do it is new. These companies are pioneers – there is no road in…
Read More
Aurora Cannabis (TSX:ACB)(NYSE:ACB) and Canada Goose Holdings (TSX:GOOS)(NYSE:GOOS) are two popular Canadian stocks. The two stocks have recently hit new 52-week lows. Buying a stock that’s hit a 52-week low and that rebounds after is a profitable strategy. But there is a risk that the stock might go down further. It’s therefore important to look at a company’s outlook to…
Read More
Even in its short history, Cannabis investing has been full of victory and defeat. In 2018, every pot stock was soaring in value. By 2019, the fortunes were reversed, with the majority of pot stocks falling by at least 50%. Here’s what you need to know: this ride is far from over. In 2020, we could see another upward surge.…
Read More
Canopy Growth (TSX:WEED)(NYSE:CGC) is a favourite among cannabis investors. With a $10.3 billion market cap, the stock is priced above nearly every competitor. One of the biggest reasons for this valuation is Canopy’s partnership with Constellation Brands. With a $40 billion valuation, Constellation is an industry heavyweight, too. But instead of pot, Constellation is focused on alcohol. Last year, it…
Read More
While the battle among Canadian marijuana producers for Europe market dominance continues to shape up in 2020, clear winners are emerging judging from recent licensing developments, capacity analysis and related strategic moves from the respective challengers. Aurora Cannabis (TSX:ACB)(NYSE:ACB) and Canopy Growth have enjoyed some first mover advantage after reporting some significant sales run rates in Germany over the past…
Read More
After booming for more than three years, the marijuana bubble started to burst in 2018 following legalization. The downhill move continued in 2019. Marijuana companies failed to meet expectations on revenue, as they had to face oversupply problems. It looks like the demand for cannabis was overestimated, and the hype has faded. With the sharp decline in stock prices, we…
Read More
Aphria (TSX:APHA)(NYSE:APHA) was one of the better-performing cannabis stocks of 2019. Although its stock declined in value for the year, it fell less than most of its peers thanks to two consecutive quarters of positive net income. Aphria’s positive earnings results in 2019 were a surprise to most investors. Cannabis stocks had broadly been expected to lose money, and few expected…
Read More
Demand for legal pot continues to climb to new heights. Investment bank Cowen Inc has raised its 2030 sales forecast from $75 billion to $80 billion, only to bump it again to $85 billion last November. Globally, several analysts are now expecting sales to peak above $200 billion. If adjacent markets are any indication, even these rosy estimates could prove…
Read More